General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-07 | 2024-03 | -0.09 | -0.12 | -0.03 | -33.33% |
2024-02-27 | 2023-12 | -0.09 | -0.09 | N/A | N/A |
2023-11-06 | 2023-09 | -0.09 | -0.11 | -0.02 | -22.22% |
2023-08-03 | 2023-06 | -0.07 | -0.03 | 0.04 | 57.14% |
2023-05-03 | 2023-03 | -0.07 | -0.02 | 0.05 | 71.43% |
2023-02-23 | 2022-12 | -0.11 | -0.11 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-06 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-06-28 | Barrington Research | Upgrade | Market Perform | Outperform |
2023-05-04 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-23 | HC Wainwright & Co. | Upgrade | Buy | |
2022-12-14 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-05-08 | BORISY ALEXIS | Director | 312.61K | Stock Award(Grant) |
2021-05-09 | COHEN JON R | Officer and Director | 125.00K | Purchase |
2024-03-17 | FROST PHILLIP MD ET AL | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2024-01-16 | HSIAO JANE H | Chief Technology Officer | 33.13M | Purchase |
2024-01-28 | KRASNO RICHARD M | Director | 0.00 | Purchase |
2024-01-07 | NABEL GARY J. | Officer and Director | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 39.31M | 85.30M | 5.09% |
2023-06-29 | Blackrock Inc. | 35.04M | 76.05M | 4.53% |
2023-06-29 | State Street Corporation | 9.14M | 19.84M | 1.18% |
2023-06-29 | Geode Capital Management, LLC | 8.74M | 18.97M | 1.13% |
2023-06-29 | Shaw D.E. & Co., Inc. | 5.70M | 12.38M | 0.74% |
2023-06-29 | Charles Schwab Investment Management, Inc. | 5.14M | 11.16M | 0.67% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 12.73M | 27.62M | 1.65% |
2023-06-29 | Vanguard Small-Cap Index Fund | 9.98M | 21.65M | 1.29% |
2023-08-30 | iShares Russell 2000 ETF | 9.24M | 16.92M | 1.20% |
2023-06-29 | Vanguard Extended Market Index Fund | 5.88M | 12.76M | 0.76% |
2023-08-30 | Invesco ETF Tr-Invesco Dynamic Biotechnology & Genome ETF | 3.88M | 7.11M | 0.50% |
2023-08-30 | iShares Russell 2000 Value ETF | 3.68M | 6.73M | 0.48% |
$OPK breaking & closing above $4 today!
$OPK $20 in 2021 mark this Post !!!!!!!
So painful watching this thing stay low when you see cars lined up for miles for testing...
$OPK law suit !! Coming for sure !!!
$OPK $3.50 $3.00 2.90 this week I will load more!
Wow. There are some really smart people here
There are also Some of the stupidest and crudest people that ever posted
Someone said “ Who cares about all your products and the number of tests”
So I do. I am a CPA. What do you think Drive shareholder value other than profit by selling products and testing
This was a very solid report demonstrated continued improvement with both Rayaldee and Somatragen
This stock is headed higher But you need some patience that isn’t demonstrated very well on this board
Good luck to all longs
$0PK WOW 500M revenues ! Let’s GO !! $15
$OPK BUY & HOLD! Vitamin D news! $15
$OPK come Monday upgrades $15
$OPK last chance to get in before we takeoff!
$OPK be a huge opening tomorrow $5-$6
$OPK here we go for another high ! $4.30
$OPK will open up huge tomorrow !! $5-$6
$OPK I buy you sell ! Sorry sellers AH sky rocket! $5
$OPK will sky rocket in AH! Great revenue $6
$OPK Come on break $4.20!
$OPK I predict 403M in revenue! EOD $4.30 AH $4.75
$OPK sell buy back lower! No momentum! $3.25
$OPK market on correction + election=buy @ $3